Tuberculosis risk in patients with Crohn’s disease on biologics: a retrospective analysis of the Japanese Medical Claims Database
TNF-α inhibitors, but not UST or VDZ, are risk factors for active TB in Japanese patients with CD.
Authors
- Masaki Ominami (ORCID: https://orcid.org/0000-0002-9692-0420)
- Yuji Nadatani (ORCID: https://orcid.org/0000-0001-7081-8746)
- Shusei Fukunaga (ORCID: https://orcid.org/0000-0002-9336-8271)
- Satoko Ohfuji (ORCID: https://orcid.org/0000-0003-3239-5249)
- Rieko Nakata (ORCID: https://orcid.org/0000-0001-9977-7239)
- Koji Fujimoto (ORCID: https://orcid.org/0009-0004-7768-2553)
- Koji Otani (ORCID: https://orcid.org/0000-0001-9075-6415)
- Shuhei Hosomi (ORCID: https://orcid.org/0000-0002-8808-5672)
- Yumie Kobayashi (ORCID: https://orcid.org/0000-0002-5747-6697)
- Fumio Tanaka (ORCID: https://orcid.org/0000-0002-9186-1249)
- Yasuhiro Fujiwara (ORCID: https://orcid.org/0000-0002-1225-1785)
- Yu Nishida (ORCID: https://orcid.org/0000-0003-3369-5059)
Institutions
- Osaka City University (JP)
- Osaka Metropolitan University (JP)
- Tokyo Metropolitan University (JP)
Publication Details
- Journal
- Intestinal Research
- Published
- 2024-08-19
- DOI
- https://doi.org/10.5217/ir.2024.00076
- Citations
- 5
- Primary Topic
- Diagnosis and treatment of tuberculosis
- Type
- article
- Field-Weighted Citation Impact
- 2.86